Vector BioMed
Latest round
- Series A
Last raised
- Jan 2023
Total raised
- $23M
Investors
- 2
About Vector BioMed
Based in Maryland, US, Vector BioMed Inc. provides platform that help its partner in clinical studies and commercialize their lentiviral vector – based medicines. As of 2023 the company is headed by its CEO Boro Dropulic. The company offers its partners with rapid access to high – titer lentiviral vectors who require to move quickly to clinical trials, and commercialization. Additionally, the firm platform produce high-titer (>10? TU/ML) Lentiviral vectors which can be used in clinical application and commercialization.
Who invested in Vector BioMed
2 investors across 2 rounds
See all investors in Vector BioMed
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vector BioMed
Who invested in Vector BioMed?
Vector BioMed has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vector BioMed raised?
Vector BioMed has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Vector BioMed last raise money?
Vector BioMed's most recent round on record is a Series A, in Jan 2023.
What does Vector BioMed do?
Based in Maryland, US, Vector BioMed Inc.
Where is Vector BioMed headquartered?
Vector BioMed is headquartered in Gaithersburg, US.
Which VCs invest in companies like Vector BioMed?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Vector BioMed's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Vector BioMed? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.